260 related articles for article (PubMed ID: 23096929)
1. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS
Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Kadota K; Colovos C; Suzuki K; Rizk NP; Dunphy MP; Zabor EC; Sima CS; Yoshizawa A; Travis WD; Rusch VW; Adusumilli PS
Ann Surg Oncol; 2012 Oct; 19(11):3598-605. PubMed ID: 22644511
[TBL] [Abstract][Full Text] [Related]
4. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
6. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
7. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma.
Kadota K; Buitrago D; Lee MC; Villena-Vargas J; Sima CS; Jones DR; Travis WD; Adusumilli PS
Lung Cancer; 2015 Sep; 89(3):329-36. PubMed ID: 26141216
[TBL] [Abstract][Full Text] [Related]
8. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS
J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
10. Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration.
Kadota K; Eguchi T; Villena-Vargas J; Woo KM; Sima CS; Jones DR; Travis WD; Adusumilli PS
Oncotarget; 2015 Sep; 6(29):27505-18. PubMed ID: 26318038
[TBL] [Abstract][Full Text] [Related]
11. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.
Kadota K; Yeh YC; Sima CS; Rusch VW; Moreira AL; Adusumilli PS; Travis WD
Mod Pathol; 2014 May; 27(5):690-700. PubMed ID: 24186133
[TBL] [Abstract][Full Text] [Related]
12. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
Arrieta O; Salas AA; Cardona AF; Díaz-García D; Lara-Mejía L; Escamilla I; García AP; Pérez EC; Raez LE; Rolfo C; Rosell R
Lung Cancer; 2021 May; 155():183-190. PubMed ID: 33558063
[TBL] [Abstract][Full Text] [Related]
13. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
[TBL] [Abstract][Full Text] [Related]
17. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
[TBL] [Abstract][Full Text] [Related]
18. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.
Westaway DD; Toon CW; Farzin M; Sioson L; Watson N; Brady PW; Marshman D; Mathur MM; Gill AJ
Pathology; 2013 Oct; 45(6):553-8. PubMed ID: 24018816
[TBL] [Abstract][Full Text] [Related]
19. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
